Indigo Paints is a decorative paints and construction chemicals company that sells emulsions, primers, putty, enamels and wood coatings through over 19,350 dealers and 55 depots, with a subsidiary Apple Chemie contributing about 7% of revenue from waterproofing and infrastructure chemicals. The business competes in a concentrated Indian market where top players control the vast majority of the industry, and Indigo holds a small 2.5% share. Yet the company earns a gross margin of 48.6% in Q4 FY26, higher than the industry leader for five consecutive years, and an EBITDA margin of 23.0% in that quarter, the second best in the industry despite being far smaller. These margins are not incidental; they persist because roughly 30% of sales come from differentiated products such as PU enamels, floor coats and metallic emulsions where Indigo holds a dominant niche share and can set prices independently. The full-year FY26 EBITDA margin was 18.5% on standalone revenue of INR1,330 crores, a clear sign that the economics of this niche-converter model are durable.
The durability of these margins rests on multiple entry barriers. Indigo manufactures more than 90% of its putty in-house, locating plants close to raw material sources, which lowers freight costs and secures supply. Its differentiated products, launched 10-15 years ago, still hold a monopolistic position because large competitors cannot justify dedicating marketing and distribution might to niche categories, creating a de facto competitive moat. The company also benefits from a strong distribution network with 12,200 tinting machines, which locks in dealer loyalty and creates switching costs for contractors who rely on consistent color matching. In the construction chemicals arm, Apple Chemie is empanelled with government agencies and supplies to major infrastructure contractors, implying long qualification cycles that competitors cannot easily bypass. These structural advantages explain why Indigo can maintain a gross margin above 48% and an EBITDA margin second only to the market leader.
The next 18 to 24 months will see Indigo's capacity and revenue base expand significantly. The new water-based plant at Jodhpur, with 90,000 KL annual capacity, is scheduled to begin trial production in June 2026, complementing the solvent-based and expanded putty plants already operational. This addresses supply chain bottlenecks for Northern and Eastern India, allowing the company to target faster growth in these underpenetrated regions. Management has guided that no major capex will be required until FY29, meaning that from FY27 onward the heavy investment phase ends and free cash flow generation strengthens materially. Apple Chemie, which grew strongly on the back of order visibility, is targeting 30%+ growth in FY27, supported by new geographies and a new sealant plant at Nagpur. By early 2028, the Jodhpur plant should be fully ramped, enabling revenue growth of double digits, up from the 4.1% standalone growth in FY26, while the company intends to keep EBITDA margins at current levels even if it sacrifices up to 2.5 percentage points of gross margin to gain share. The dividend hike of 43% to INR5 per share signals confidence in this cash-flow trajectory.
Management's execution record is mixed, but the latest guidance is clear and quantified. From the fallback data, the water-based plant was originally promised for Q3/Q4 FY26 but slipped to June 2026, and management repeatedly talked of returning to 20% growth, yet FY26 standalone revenue grew only 4.1%. However, the solvent-based plant did start on schedule and EBITDA margins expanded from 17.5% to 19.4% y/y in Q3 FY26, showing operational discipline. On the May 2026 call, management set a specific 30%+ growth target for Apple Chemie in FY27, reiterated the June 2026 commissioning date, committed to no major capex until FY29, and raised the dividend by 43%. They also stated that EBITDA margins will remain largely unchanged despite the aggressive top-line focus, backed by volume leverage. This walk-talk pattern suggests that while top-line aspirations have been missed in the past, the margin discipline and capex management have been steady, and the new plant is now in the final commissioning stages.
The quantified earnings path points to a compounder. Based on FY26 standalone EBITDA of INR246.7 crores (18.5% margin), and assuming revenue growth accelerates to, say, 12-15% in FY27 and FY28 as the new capacity ramps, EBITDA could reach the region of INR300-320 crores by FY28, with minimal incremental capex converting most of it to free cash flow. The key assumption is that the Jodhpur water-based plant actually starts trial production in June 2026 and ramps without further slips, and that Apple Chemie's 30% growth is delivered. The single biggest falsifier would be another delay in commissioning or a demand slump that forces the company to cut prices more than planned, which would compress the 2-2.5 percentage point gross margin tolerance and erode EBITDA. The tension between a 4.1% FY26 revenue growth and the high-teens growth promise is resolved by the operational ramp: the new plant and the Apple Chemie order book provide the capacity and demand visibility to close that gap. If management hits these milestones, the business in 18-24 months will be a higher-revenue, higher-free-cash-flow entity with a larger share in the premium segment and a stable margin structure.
companyname: Indigo Paints Limited ticker: INDIGOPNTS sector: Decorative Paints & Coatings Indigo Paints Limited is a decorative paint manufacturer founded in 2000 in Pune. It started with a single cement paint product and has grown into India's fifth-largest decorative paint company by scale, with FY26 consolidated revenue of ₹1,405 crores (4.8% growth over FY25's ₹1,340.67 crores). The company sells interior and exterior emulsions, enamels, putties, primers, distempers, wood coatings, waterpr...
Read the full report →capex, new product segment, geographic expansion, market share gain
FY27 Apple Chemie revenue growth guided at 30% plus driven by order visibility and brand recognition
Guidance no_datamixed
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Indigo Paints Limited and 4,900+ companies.
5-day free pass. No card required.